Upper Limb Blood Flow Restriction in Handball Players

Sports Physical Therapy Clinical Trial

Official title:

Efficacy of Upper Limb Blood Flow Restriction in Handball Players. Randomised Clinical Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06423196
• Other study ID #: Floss-Hand
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 19, 2024
• Est. completion date: July 1, 2024

Study information

• Verified date: May 2024
• Source: Universidad Católica San Antonio de Murcia
• Contact: Rubén Cuesta-Barriuso, PhD
• Phone: 607547274
• Email: cuestaruben[@]uniovi.es
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Introduction. Blood flow restriction therapy involves the use of an occlusion cuff placed over an extremity resulting in a partial reduction of arterial blood flow and total restriction of venous return.

Objectives. To analyse the efficacy of a physiotherapy intervention using blood flow restriction in improving upper limb strength in adult handball players.

Methods. Randomised, single-blind, clinical study. 20 athletes will be recruited and randomly assigned to the experimental and control groups. The intervention of the experimental group will consist of performing an exercise protocol after blood flow restriction. The intervention period will last 4 weeks, with a periodicity of 2 weekly sessions of 30 minutes each. The primary variable will be the strength of the triceps, epicondyle and epitrochlear musculature (pressure hand dynamometer). The secondary variable will be the muscle activation of this musculature (surface electromyography).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: July 1, 2024
• Est. primary completion date: June 15, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Athletes over 18 years of age.

• Federated in handball at the time of the study.

• No lower limb injuries in the three months prior to the study.

• Signing the informed consent document.

Exclusion Criteria:

• Athletes who have undergone surgery in the year prior to the study.

• People who do not attend at least 80% of the treatment sessions.

• Players who are receiving physiotherapy treatment in parallel to the physical preparation of the team they are playing for.

Related Conditions & MeSH terms

• Sports Physical Therapy

Intervention

Other:
• Experimental group
In the development of the exercises, the players will mobilise dumbbells of different weights that will be estimated according to the calculation of 30% of 1 RM. This workload with dumbbells is based on previous work where blood flow restriction was used in healthy athletes.

Locations

Country	Name	City	State
Spain	Universidad Católica San Antonio, Murcia	Murcia

Sponsors (1)

Lead Sponsor	Collaborator
Universidad Católica San Antonio de Murcia

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assess the muscle strength at screening visit	Muscle strength will be assessed with a pressure dynamometer (Lafayette Manual Muscle model). The strength of the triceps brachii, epicondyle and epitrochlear musculature will be measured. The evaluation protocol used by Morin et al. will be used. The unit of measurement is the Newton (the higher the value, the greater the muscle strength). The measurements are taken bilaterally. The mean value of the 2 measurements taken shall be used as a measure.	Screening visit, within the first seven days after treatment and after four weeks follow-up
Secondary	Assess the muscle activation at screening visit	Muscle activation will be measured by surface electromyography (model SHIMMMER2, Shimmer, Ireland). Electrode placement will be marked on standing subjects, and will be positioned according to European recommendations for the use of surface electromyography. A bipolar SEMG system will be used with circular electrodes of 10 mm diameter, 20 mm apart, placed longitudinally, in the direction of the muscle fibres under study, and with a reference electrode at a distance. The unit of measurement is µV, where the higher the score, the greater the muscle activation.	Screening visit, within the first seven days after treatment and after four weeks follow-up